Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species

Virology

Volumn 433, Issue 2, 2012, Pages 385-394

  Handisurya, Alessandra ^a,b   Day, Patricia M ^a   Thompson, Cynthia D ^a   Buck, Christopher B ^a   Kwak, Kihyuck ^c   Roden, Richard B S ^c   Lowy, Douglas R ^a   Schiller, John T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Universitatsklinik fur Dermatologie   (Austria)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

In vivo imaging; Murine model; Murine papillomavirus; Papillomavirus; Pseudovirions; Skin infection; Tissue tropism

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CONTROLLED STUDY; FEMALE; GENETIC TRANSDUCTION; GENITAL SYSTEM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 8; IN VIVO STUDY; INFECTION SENSITIVITY; KERATINOCYTE; MURINE PAPILLOMA VIRUS; NONHUMAN; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PSEUDOVIRION; SKIN; SKIN INFECTION; SKIN INJURY; VAGINA MUCOSA; VIRAL TROPISM; VIRION; VIRUS ENTRY; VIRUS STRAIN;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENES, REPORTER; HUMANS; KERATINOCYTES; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; ORGAN SPECIFICITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN; SPECIES SPECIFICITY; VAGINA; VIRION; VIRULENCE;

ANIMALIA; HUMAN PAPILLOMAVIRUS; MURINAE; MUS; PAPILLOMAVIRIDAE;

EID: 84867206591     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.035     Document Type: Article

References (35)

1. Aguilera-Barrantes I., Magro C., Nuovo G.J. Verruca vulgaris of the vulva in children and adults: a nonvenereal type of vulvar wart. Am. J. Surg. Pathol. 2007, 31(4):529-535.
2. Alphs H.H., Gambhira R., Karanam B., Roberts J.N., Jagu S., Schiller J.T., Zeng W., Jackson D.C., Roden R.B. Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc. Nat. Acad. Sci. U.S.A. 2008, 105(15):5850-5855.
3. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401(1):70-79.
4. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 2004, 78(2):751-757.
5. Buck, C.B., Thompson, C.D., 2007. Production of papillomavirus-based gene transfer vectors. Curr. Protoc. Cell Biol. 26, 26.1.
6. Cladel N.M., Hu J., Balogh K., Mejia A., Christensen N.D. Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection. J. Virol. Methods 2008, 148(1-2):34-39.
7. Day P.M., Kines R.C., Thompson C.D., Jagu S., Roden R.B., Lowy D.R., Schiller J.T. In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microb. 2010, 8(3):260-270.
8. de Villiers E.M. Heterogeneity of the human papillomavirus group. J. Virol. 1989, 63(11):4898-4903.
9. Forslund O., Nordin P., Hansson B.G. Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers. Br. J. Dermatol. 2000, 142(6):1148-1153.
10. Gambhira R., Karanam B., Jagu S., Roberts J.N., Buck C.B., Bossis I., Alphs H., Culp T., Christensen N.D., Roden R.B. A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J. Virol. 2007, 81(24):13927-13931.
11. García-Vallvé S., Iglesias-Rozas J.R., Alonso A., Bravo I.G. Different papillomaviruses have different repertoires of transcription factor binding sites: convergence and divergence in the upstream regulatory region. BMC Evol. Biol. 2006, 6:20.
12. Gewirtzman A., Bartlett B., Tyring S. Epidermodysplasia verruciformis and human papilloma virus. Curr. Opin. Infect. Dis. 2008, 21(2):141-146.
13. Handisurya A., Rieger A., Bankier A., Koller A., Salat A., Stingl G., Kirnbauer R. Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. Br. J. Dermatol. 2007, 157(4):788-794.
14. High W.A., Tyring S.K., Taylor R.S. Rapidly enlarging growth of the proximal nail fold. Dermatol. Surg. 2003, 29(9):984-986.
15. Howley P.M., Lowy D.R. Papillomavirus. Fields Virology 2007, 2299-2354. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
16. Ingle A., Ghim S., Joh J., Chepkoech I., Bennett Jenson A., Sundberg J.P. Novel laboratory mouse papillomavirus (MusPV) infection. Vet. Pathol. 2011, 48(2):500-505.
17. Johnson K.M., Kines R.C., Roberts J.N., Lowy D.R., Schiller J.T., Day P.M. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J. Virol. 2009, 83(5):2067-2074.
18. Kines R.C., Thompson C.D., Lowy D.R., Schiller J.T., Day P.M. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc. Nat. Acad. Sci. U.S.A. 2009, 106(48):20458-20463.
19. Kondo K., Ishii Y., Mori S., Shimabukuro S., Yoshikawa H., Kanda T. Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions. Virology 2009, 394(2):259-265.
20. Kreuter A., Brockmeyer N.H., Pfister H., Altmeyer P., Wieland U. Human papillomavirus type 26-associated periungual squamous cell carcinoma in situ in a HIV-infected patient with concomitant penile and anal intraepithelial neoplasia. J. Am. Acad. Dermatol. 2005, 53(4):737-739. Competence Network HIV/AIDS.
21. Kreuter A., Gambichler T., Pfister H., Wieland U. Diversity of human papillomavirus types in periungual squamous cell carcinoma. Br. J. Dermatol. 2009, 161(6):1262-1269.
22. Lindel K., Helmke B., Simon C., Weber K.J., Debus J., de Villiers E.M. Cutaneous human papillomavirus in head and neck squamous cell carcinomas. Cancer Invest. 2009, 27(7):781-787.
23. Mejia A.F., Culp T.D., Cladel N.M., Balogh K.K., Budgeon L.R., Buck C.B., Christensen N.D. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles. J. Virol. 2006, 80(24):12393-12397.
24. Mistry N., Simonsson M., Evander M. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. Virol. J. 2007, 4:27.
25. Mistry N., Wibom C., Evander M. Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism. Virol. J. 2008, 5:118.
26. Müller M., Gissmann L., Cristiano R.J., Sun X.Y., Frazer I.H., Jenson A.B., Alonso A., Zentgraf H., Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 1995, 69(2):948-954.
27. Pastrana D.V., Buck C.B., Pang Y.Y., Thompson C.D., Castle P.E., FitzGerald P.C., Krger-Kjaer S., Lowy D.R., Schiller J.T. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 2004, 321(2):205-216.
28. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., Lowy D.R., Schiller J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13(7):857-861.
29. Roden R.B., Kirnbauer R., Jenson A.B., Lowy D.R., Schiller J.T. Interaction of papillomaviruses with the cell surface. J. Virol. 1994, 68(11):7260-7266.
30. Schiller J.T., Day P.M., Kines R.C. Current understanding of the mechanism of HPV infection. Gynecol. Oncol. 2010, 118(1 Suppl):S12-17.
31. Steinberg B.M., Auborn K.J., Brandsma J.L., Taichman L.B. Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes. J. Virol. 1989, 63(2):957-960.
32. Stepp M.A., Spurr-Michaud S., Tisdale A., Elwell J., Gipson I.K. Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc. Nat. Acad. Sci. U.S.A. 1990, 87(22):8970-8974.
33. Syrjanen S. Human papillomavirus infections and oral tumors. Med. Microbiol. Immunol. 2003, 192(3):123-128.
34. Turnbull J., Powell A., Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 2001, 11(2):75-82.
35. Volpers C., Unckell F., Schirmacher P., Streeck R.E., Sapp M. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 1995, 69(6):3258-3264.